Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WDB coco CoTSE:7079 +0.23%67 Return-on-Tangible-Equity is 19.76% as of Mar. 2026, which is 35% below its 10-year median of 30.31. GuruFocus rates TSE:7079 with a GF Score™ of 67/100 and a GF Value™ of 円3,586.18 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 584 Healthcare Providers & Services companies, WDB coco Co ranks better than 60.45% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. WDB coco Co's annualized net income for the quarter that ended in Mar. 2026 was 円887 Mil. WDB coco Co's average shareholder tangible equity for the quarter that ended in Mar. 2026 was 円4,491 Mil. Therefore, WDB coco Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 19.76%.
The historical rank and industry rank for WDB coco Co's Return-on-Tangible-Equity or its related term are showing as below:
TSE:7079'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 15.02 Med: 30.31 Max: 40.16
Current: 15.02
During the past 9 years, WDB coco Co's highest Return-on-Tangible-Equity was 40.16%. The lowest was 15.02%. And the median was 30.31%.
TSE:7079's Return-on-Tangible-Equity is ranked better than 60.45% of 584
companies
in the Healthcare Providers & Services industry
Industry Median: 10.74
vs TSE:7079: 15.02
WDB coco Co (TSE:7079) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
WDB coco Co Return-on-Tangible-Equity Related Terms
WDB coco Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for WDB coco Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7079 vs VEEV, BTSG, TEM: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, WDB coco Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WDB coco Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where WDB coco Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 19.76% mean?
WDB coco Co (TSE:7079) has a Return-on-Tangible-Equity of 19.76% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on WDB coco Co and its competitors. This is 35% below median its historical median of 30.31. Over the past decade, WDB coco Co's Return-on-Tangible-Equity has ranged from 15.02 to 40.16. According to the industry distribution chart, WDB coco Co ranks #231 out of 584 companies in the Healthcare Providers & Services industry, placing it in the top 39.6%.
Is WDB coco Co's Return-on-Tangible-Equity too high?
WDB coco Co's current Return-on-Tangible-Equity of 19.76% is 35% below median its 10-year median of 30.31. Over the past 10 years, this metric has ranged from a low of 15.02 to a high of 40.16. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.74. WDB coco Co's value of 19.76% is 84% above this industry median. Based on the distribution chart, WDB coco Co ranks #231 out of 584 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, WDB coco Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WDB coco Co's Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, WDB coco Co ranks #231 out of 584 companies for Return-on-Tangible-Equity. This puts WDB coco Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.74. WDB coco Co's value of 19.76% is 84% above this benchmark. Historically, WDB coco Co's own Return-on-Tangible-Equity has ranged from 15.02 to 40.16 over the past decade. While the company's 10-year median is 30.31 vs. the industry median of 10.74, WDB coco Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.74, based on 584 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WDB coco Co's current Return-on-Tangible-Equity of 19.76% is 84% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on WDB coco Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WDB coco Co's current Return-on-Tangible-Equity is 19.76%, which is 35% below median its own 10-year median of 30.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WDB coco Co stock overvalued right now?
Based on GuruFocus' analysis, WDB coco Co (TSE:7079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,586.18, compared to a current price of 円2,561.00 — trading 28.6% below its estimated fair value. The current Return-on-Tangible-Equity is 19.76%, which is 35% below median its 10-year median of 30.31 and 84% above the Healthcare Providers & Services industry median of 10.74. WDB coco Co's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For WDB coco Co (TSE:7079), the current Return-on-Tangible-Equity is 19.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WDB coco Co (TSE:7079) Overvalued in 2026?
Based on GuruFocus' analysis, WDB coco Co stock appears to be undervalued.
The current stock price of 円2,561.00 is trading 28.6% below its estimated GF Value™ of 円3,586.18.
GuruFocus considers WDB coco Co to be Modestly Undervalued.
Key valuation signals for TSE:7079:
Return-on-Tangible-Equity: 19.76% (35% below median its 10-year median of 30.31)
GF Value™: 円3,586.18 vs. price of 円2,561.00 (28.6% below fair value)
Industry Position: 84% above the Healthcare Providers & Services median (#231 of 584)
No single metric tells the full story. See the TSE:7079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC-related work, PMS facility contract support related work, clinical research support/monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments, such as monitoring, safety information, data management, and statistical analysis. It provides support for the development of generic drugs, such as bioequivalence studies and biosimilars, clinical research, and physician-led clinical trials.
67GF Score
Get the complete analysis for TSE:7079
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7079 has been successfully added to your 
